Table 4 Contents of β-artemether and lumefantrine in fixed dose combination (FDC) products (n=6)
FDC samples | Batch/Lot No. | Content (%) ± S.D. | |
|---|---|---|---|
β-artemether | Lumefantrine | ||
Artemine® tablets | A | 103.2 ± 1.5 | 101.5 ± 0.9 |
B | 102.2 ± 1.7 | 101.3 ± 0.5 | |
Coartem® tablets | A | 98.2 ± 0.9 | 97.92 ± 0.7 |
B | 99.2 ± 1.5 | 98.8 ± 0.7 | |
Co-Artesiane powder for oral suspension | A | 100.9 ± 1.9 | 101.4 ± 0.9 |
B | 99.7 ± 1.6 | 102.0 ± 0.8 | |
C | 101.1 ± 1.3 | 100.8 ± 0.8 | |